Maartje M van de Meeberg

6PUBLICATIONS
0CO-AUTHORS
Medical infection agents (incl. prions)Medical biochemistry - proteins and peptides (incl. medical proteomics)Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2024
Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn's disease.

Maartje M van de Meeberg, Janani Sundaresan, Marry Lin

|Dec 12, 2023
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply.

Maartje M van de Meeberg, Herma H Fidder, Robert de Jonge

|Sep 28, 2023
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.

Maartje M van de Meeberg, Herma H Fidder, Bas Oldenburg

|Feb 24, 2023
Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis.

Maartje M van de Meeberg, Elwin R Verheij, Herma H Fidder

|Nov 03, 2022
A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.

Maartje M van de Meeberg, Renske C F Hebing, Michael T Nurmohamed

|Jul 30, 2022
Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease: a cross-sectional study.

M M van de Meeberg, M L Seinen, H H Fidder

Pageof 1

Frequent Collaborators